JIANGSU HENGRUI PHARMACEUTICALS CO LTD (UI)
Clinical trial NCT05742750 updates: 1. status: UNKNOWN → COMPLETED 2. start date: 2023-03-01 → 2023-04-27 3. completion date: 2024-12-30 → 2026-05-30 4. primary completion date: 2023-12-30 → 2025-12-01 5. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (72%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (18%) **Content type:** Clinical